Accessibility Menu
 
Jupiter Neurosciences logo

Jupiter Neurosciences

(NASDAQ) JUNS

Current Price$0.37
Market Cap$14.28M
Since IPO (2024)-93%
5 YearN/A
1 Year-28%
1 Month-7%

Jupiter Neurosciences Financials at a Glance

Market Cap

$14.28M

Revenue (TTM)

$21.80K

Net Income (TTM)

$8.64M

EPS (TTM)

$-0.26

P/E Ratio

-1.54

Dividend

$0.00

Beta (Volatility)

0.33 (Low)

Price

$0.37

Volume

150,879.036

Open

$0.41

Previous Close

$0.39

Daily Range

$0.35 - $0.41

52-Week Range

$0.31 - $3.33

JUNS News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Jupiter Neurosciences

Industry

Pharmaceuticals

Employees

5

CEO

Christer Rosén

Headquarters

Jupiter, FL 33477, US

JUNS Financials

Key Financial Metrics (TTM)

Gross Margin

100%

Operating Margin

-409%

Net Income Margin

-397%

Return on Equity

-739%

Return on Capital

5%

Return on Assets

-2%

Earnings Yield

-64.94%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$14.28M

Shares Outstanding

36.28M

Volume

150.88K

Short Interest

0.00%

Avg. Volume

323.72K

Financials (TTM)

Gross Profit

$17.57K

Operating Income

$8.91M

EBITDA

$8.58M

Operating Cash Flow

$5.41M

Capital Expenditure

$4.00

Free Cash Flow

$5.41M

Cash & ST Invst.

$3.79M

Total Debt

$5.32M

Jupiter Neurosciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$21.80K

N/A

Gross Profit

$21.80K

N/A

Gross Margin

100.00%

N/A

Market Cap

$14.28M

N/A

Market Cap/Employee

$3.57M

N/A

Employees

4

N/A

Net Income

$2.58M

-68.6%

EBITDA

$2.51M

-67.8%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$1.53M

-143.1%

Accounts Receivable

$0.00

N/A

Inventory

$159.79K

N/A

Long Term Debt

$0.00

-100.0%

Short Term Debt

$5.32M

+2606.8%

Return on Assets

-1.55%

N/A

Return on Invested Capital

4.86%

N/A

Free Cash Flow

$2.37M

+35.9%

Operating Cash Flow

$2.37M

+35.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
GNTAGenenta Science S.p.A.
$0.64-0.22%
SERSerina Therapeutics, Inc.
$1.93-1.53%
ABVCABVC BioPharma, Inc.
$1.36-1.45%
SKYESkye Bioscience, Inc.
$0.82+12.77%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$63.81-0.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$11.54+0.07%
AALAmerican Airlines Group
$12.13+0.08%
SNAPSnap
$5.60+0.09%

Questions About JUNS

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.